Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays

Show other versions (1)

Clinicians should be aware of new developments to familiarize themselves with pharmacokinetic and pharmacodynamic characteristics of new anticoagulant agents to appropriately and safely use them. For the moment, cardiologists and other clinicians also require to master currently available drugs, rea...

Full description

Bibliographic Details
Main Authors:	Hamidreza Goodarzynejad, Mohammadali Boroumand
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2010-05-01
Series:	Journal of Tehran University Heart Center
Subjects:	Anticoagulants Heart International Normalized Ratio Partial Thromboplastin Prothrombin Time
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15530.pdf&manuscript_id=15530

Similar Items

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
by: Mohammadali Boroumand, et al.
Published: (2010-04-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01)

Unified Methodology for the Primary Preclinical In Vivo Screening of New Anticoagulant Pharmaceutical Agents from Hematophagous Organisms
by: Maria A. Kostromina, et al.
Published: (2024-04-01)

Influence of Oral Dipping Tombak Smokeless Tobacco on Coagulation Profile and Platelet Counts
by: Ahmed M. E. Elkhalifa, et al.
Published: (2022-04-01)

The Association between Blood Coagulation Parameters and Glasgow Coma Scale in Patients with Head Trauma Admitted to Intensive Care Unit
by: Azadeh Bahadori, et al.
Published: (2018-10-01)

Potential Anticoagulant Activity of Thymus atlanticus Leaves Part in vitro on Normal Plasma Samples
by: Mothana Abdullah Elhussein, et al.
Published: (2022-06-01)

Comparison between Homocysteine, Fibrinogen, PT, PTT, INR and CRP in Male Smokers with/without Addiction to Opium
by: Nahid Azdaki, et al.
Published: (2017-05-01)

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
by: Eleonora Camilleri, et al.
Published: (2021-10-01)

Evaluation of anticoagulant and thrombolytic activity of Berberis orthobotrys in animal model
by: . Alamgeer, et al.
Published: (2018-06-01)

Periprocedural Coagulation Status in Percutaneous Interventions
by: Soumil Singhal, et al.
Published: (2019-12-01)

Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit
by: Vanessa M. Silva, et al.
Published: (2020-11-01)

Biological evaluation of the effect of sugammadex on hemostasis and bleeding
by: Julien Raft, et al.
Published: (2015-02-01)

The changes in the fibrinogen concentration and coagulation pathways in winter and summer in cattle
by: ameneh khoshvaghti
Published: (2013-08-01)

Lupus Anticoagulant Detection under the Magnifying Glass
by: Angelo Claudio Molinari, et al.
Published: (2023-10-01)

Drug-Related Problems and Factors Involved in the Imbalance of Oral Anticoagulants in Lebanese Patients: A Cross-Sectional Study
by: Soukeina Bassam, et al.
Published: (2022-06-01)

The effects of Ramadan fasting on patients with prosthetic heart valve taking warfarin for anticoagulation
by: Muhammad O. Awiwi, et al.
Published: (2017-01-01)

The frequency and timing of sepsis-associated coagulopathy in the neonatal intensive care unit
by: Khyzer B. Aziz, et al.
Published: (2024-03-01)

Effect of plasma storage on prothrombin time and activated partial thromboplastin time at a Nigerian public laboratory
by: Mohammed A Ndakotsu, et al.
Published: (2013-01-01)

Prothrombin time and activated partial thromboplastin time in women with gestational diabetes mellitus
by: Samira Mahjabeen, et al.
Published: (2023-01-01)

Effect of Haemodialysis on Mean Prothrombin Time and Activated Partial Thromboplastin Time in Patients of End Stage Renal Disease
by: Attika Khalid
Published: (2015-12-01)

Variations in activated partial thromboplastin time and prothrombin time in individuals of A, B, AB, and O blood groups
by: Chizoba Okechukwu Okeke, et al.
Published: (2018-01-01)

Green tea consumption effects on coagulation profile
by: Ahmed Mohammed Elnour Elkhalifa, et al.
Published: (2020-01-01)

Hemostatic abnormalities in children with thalassemia major and liver iron overload
by: Pustika Amalia Wahidiyat, et al.
Published: (2018-08-01)

Current Controversies in Lupus Anticoagulant Detection
by: Gary W. Moore
Published: (2016-12-01)

Transmission of lupus anticoagulant by allogeneic stem cell transplantation
by: Mira Romany Massoud, et al.
Published: (2014-07-01)

In vivo examination of the anticoagulant effect of the Brassica oleracea methanol extract
by: Khan Rafeeq Alam, et al.
Published: (2015-01-01)

Coagulation profile alterations in dogs co-infected with visceral leishmaniasis and monocytic ehrlichiosis
by: Canberk BALIKÇI, et al.
Published: (2023-09-01)

Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study
by: Rehan Ahmed, et al.
Published: (2019-01-01)

Should multiple factor dilutions be performed for all patient coagulation factor assays? Let the debate begin!
by: Emmanuel J. Favaloro, et al.
Published: (2022-02-01)

Analysis of D-Dimer Level and Prothombin Time (PT) Activated Prothombin Thromboplastin (APTT) on Heparin Administration to COVID-19 Patients
by: Dela Yorike, et al.
Published: (2022-04-01)

Comparative analysis of platelet depleted plasma prepared on the Roche 8100 automation line and manually centrifuged platelet poor plasma for routine coagulation assays
by: Mustafa A. Barbhuiya, et al.
Published: (2023-08-01)

An Agreement Study Between Point-of-Care and Laboratory Activated Partial Thromboplastin Time for Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation
by: Yuan Teng, et al.
Published: (2022-06-01)

STANDARDIZATION OF PROTHROMBIN TIME TEST AND EVALUATION OF QUALITY OF PATIENT MANAGEMENT WITH WARFARIN
by: A.H ZARGARZADEH, et al.
Published: (2000-12-01)

Early Fresh Frozen Plasma Transfusion: Is It Associated With Improved Outcomes of Patients With Sepsis?
by: Xiaoyi Qin, et al.
Published: (2021-11-01)

Activation of coagulation system and d-dimer levels in children with acute leukemia
by: Harun Wijaya, et al.
Published: (2014-08-01)

The Influence of Sustained Mercury Exposure on Prothrombin Time and Partial Thromboplastin Time among Sudanese Gold Mining Workers
by: Rimonda Emil Tadros, et al.
Published: (2022-06-01)

Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and Art Status
by: R Thulasi Raman, et al.
Published: (2016-05-01)

Association of aPTT-Guided Anticoagulation Monitoring with Thromboembolic Events in Patients Receiving V-A ECMO Support: A Systematic Review and Meta-Analysis
by: Sasa Rajsic, et al.
Published: (2023-04-01)

Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement
by: Le Geng, et al.
Published: (2023-06-01)

Risk for excessive anticoagulation during hemodialysis is associated with type of vascular access and bedside coagulation testing: Results of a cross-sectional study
by: Marijke De Troyer, et al.
Published: (2022-12-01)